In JAVELIN Bladder 100, 358 patients (51.1%) had PD-L1–positive tumors, 270 patients (38.6%) had negative tumors, and 72 patients (10.3%) had unknown tumor status per the SP263 assay label. The gene discussed is CD274; the disease is neoplasm.